Keyware Solutions (3799) · InitiativeAdvanced
Enhancement of the Pathology Testing System “Medlas-BR”
First written in FY2024. 1 of 2 entries say "Advanced", first in FY2025-H1. Latest entry: FY2025-H1.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Enhancement of Medical System Functionality and Sophistication of Customer SupportA theme 9 companies write about · 0 as a headwind · 12 as a tailwind
The whole theme swung hardest in 2023: 1 of 7 companies on the "Worse" side.
5 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2025-H1AdvancedAnnual report
「The Company significantly enhanced the functionality of Medlas-BR, its flagship pathology testing system and internally developed software package for medical institutions, and began offering the enhanced system.」
For the Medlas-BR pathology testing system, the Company disclosed specific progress in addition to the functional enhancement, namely the start of offering the enhanced system. - FY2024First statedAnnual report
「The Company has significantly enhanced the functionality of Medlas-BR, its flagship pathology testing system and an internally developed software package for medical institutions.」
As an initiative to strengthen the medical solutions business, the Company has, for the first time, separately identified the significant enhancement of its flagship Medlas-BR product's functionality as an initiative.